Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 12, 2025 | (Q1)Jul 20, 2025 | (FY)Apr 27, 2025 | (Q4)Apr 27, 2025 | (Q3)Feb 2, 2025 | (Q2)Oct 13, 2024 | (Q1)Jul 21, 2024 | (FY)Apr 28, 2024 | (Q4)Apr 28, 2024 | (Q3)Feb 4, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.65%17.87B | -5.09%17.35B | 5.19%72.86B | -7.52%16.27B | 6.53%20.9B | 5.96%17.41B | 16.99%18.28B | -3.61%69.26B | 8.17%17.59B | 19.62B |
| Operating revenue | 2.65%17.87B | -5.09%17.35B | 5.19%72.86B | -7.52%16.27B | 6.53%20.9B | 5.96%17.41B | 16.99%18.28B | -3.61%69.26B | 8.17%17.59B | --19.62B |
| Cost of revenue | 1.44%14.46B | -7.09%14.03B | 4.67%59.84B | -9.95%13.34B | 5.93%17.14B | 5.67%14.25B | 19.07%15.1B | -4.41%57.17B | 10.90%14.81B | 16.18B |
| Gross profit | 8.12%3.41B | 4.44%3.31B | 7.63%13.02B | 5.45%2.93B | 9.38%3.76B | 7.30%3.15B | 7.99%3.17B | 0.38%12.1B | -4.37%2.78B | 3.44B |
| Operating expense | 9.62%2.32B | 7.89%2.24B | 11.64%9.28B | 6.24%2.3B | 11.12%2.79B | 15.21%2.12B | 15.21%2.07B | 5.19%8.32B | 7.10%2.17B | 2.51B |
| Depreciation amortization depletion | 14.25%534.1M | 19.71%527.8M | 19.62%2.11B | 9.81%540.8M | 22.08%656.2M | 26.49%467.5M | 22.30%440.9M | 15.35%1.76B | 26.41%492.5M | --537.5M |
| -Depreciation and amortization | 14.25%534.1M | 19.71%527.8M | 19.62%2.11B | 9.81%540.8M | 22.08%656.2M | 26.49%467.5M | 22.30%440.9M | 15.35%1.76B | 26.41%492.5M | --537.5M |
| Other operating expenses | 8.31%1.79B | 4.70%1.71B | 9.50%7.18B | 5.19%1.76B | 8.14%2.14B | 12.37%1.65B | 13.44%1.63B | 2.76%6.56B | 2.49%1.67B | --1.98B |
| Operating profit | 5.04%1.09B | -2.06%1.08B | -1.18%3.74B | 2.65%631.1M | 4.66%972M | -5.92%1.03B | -3.43%1.1B | -8.80%3.78B | -30.57%614.8M | 928.7M |
| Net non-operating interest income (expenses) | -15.16%-144.3M | -14.20%-133.5M | -31.01%-504M | 14.49%-89.1M | -27.27%-172.7M | -64.01%-125.3M | -70.91%-116.9M | -47.11%-384.7M | -92.96%-104.2M | -135.7M |
| Non-operating interest income | -25.36%25.9M | -21.34%31.7M | -7.96%138.8M | -22.80%25.4M | -26.72%38.4M | 0.87%34.7M | 29.58%40.3M | 60.60%150.8M | 22.30%32.9M | --52.4M |
| Non-operating interest expense | 6.85%170.1M | 3.52%161.7M | 24.32%642.6M | -9.37%118M | 17.86%209.2M | 46.19%159.2M | 55.73%156.2M | 46.47%516.9M | 57.25%130.2M | --177.5M |
| Total other finance cost | -87.50%100K | 250.00%3.5M | -98.92%200K | -150.72%-3.5M | -82.08%1.9M | -57.89%800K | 225.00%1M | 644.00%18.6M | 463.16%6.9M | --10.6M |
| Other net income (expenses) | -2.33%21M | 66.19%80.6M | 72.83%89.7M | 151.06%2.4M | 127.63%17.3M | -44.73%21.5M | 380.20%48.5M | 15.08%51.9M | -291.67%-4.7M | 7.6M |
| Gain on sale of security | 18.67%8.9M | 744.44%15.2M | -2.46%27.8M | 235.00%5.4M | 142.59%13.1M | -74.49%7.5M | 178.26%1.8M | 208.37%28.5M | 84.67%-4M | --5.4M |
| Special income (charges) | -70.59%1.5M | 56.66%60M | 1,491.67%33.4M | -46.51%-6.3M | -164.29%-3.7M | 2,650.00%5.1M | 994.29%38.3M | -103.55%-2.4M | -114.68%-4.3M | ---1.4M |
| -Gain on sale of property,plant,equipment | -70.59%1.5M | 56.66%60M | 1,491.67%33.4M | -46.51%-6.3M | -164.29%-3.7M | 2,650.00%5.1M | 994.29%38.3M | -103.55%-2.4M | -114.68%-4.3M | ---1.4M |
| Income before tax | 3.51%962.4M | -0.70%1.02B | -3.65%3.32B | 7.61%544.4M | 2.00%816.6M | -12.37%929.8M | -4.55%1.03B | -12.24%3.45B | -39.07%505.9M | 800.6M |
| Income tax | 0.60%219.1M | -0.08%238M | 1.93%729.7M | 98.64%102.1M | -2.61%171.6M | -9.96%217.8M | -3.33%238.2M | -14.59%715.9M | -67.79%51.4M | 176.2M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 4.40%743.3M | -0.88%786.1M | -5.12%2.59B | -2.68%442.3M | 3.30%645M | -13.09%712M | -4.92%793.1M | -11.61%2.73B | -32.23%454.5M | 624.4M |
| Net income continuous operations | 4.40%743.3M | -0.88%786.1M | -5.12%2.59B | -2.68%442.3M | 3.30%645M | -13.09%712M | -4.92%793.1M | -11.61%2.73B | -32.23%454.5M | --624.4M |
| Noncontrolling interests | -15.63%2.7M | 56.52%3.6M | 380.00%12M | 93.33%2.9M | 260.00%3.6M | 3.2M | 2.3M | 2.5M | 1.5M | 1M |
| Net income attributable to the company | 4.49%740.6M | -1.05%782.5M | -5.47%2.58B | -3.00%439.4M | 2.89%641.4M | -13.48%708.8M | -5.19%790.8M | -11.69%2.73B | -32.46%453M | 623.4M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 4.49%740.6M | -1.05%782.5M | -5.47%2.58B | -3.00%439.4M | 2.89%641.4M | -13.48%708.8M | -5.19%790.8M | -11.69%2.73B | -32.46%453M | 623.4M |
| Diluted earnings per share | 5.33%0.79 | 0.00%0.83 | -3.55%2.72 | 0.00%0.47 | 4.62%0.68 | -11.76%0.75 | -2.35%0.83 | -8.14%2.82 | -31.88%0.47 | 0.65 |
| Basic earnings per share | 5.33%0.79 | -1.20%0.82 | -3.90%2.71 | -2.13%0.46 | 4.62%0.68 | -11.76%0.75 | -2.35%0.83 | -7.84%2.82 | -30.88%0.47 | 0.65 |
| Dividend per share | 8.17%0.1401 | 11.54%0.1425 | 14.09%0.5327 | 5.21%0.1363 | 8.04%0.1391 | 25.76%0.1295 | 20.97%0.1278 | 24.19%0.4669 | 25.13%0.1295 | 0.1288 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.